Trial intelligence / Profile preview

ICON: N-acetylcysteine in Asthma

NCT03581084Phase 4Terminated

Sponsor
University of California, San Francisco
Start
Jul 2018
Primary completion
Jul 2018
Countries
1
01

Overview

A Phase 4 trial of acetylcysteine inhalation solution in asthma, sponsored by University of California, San Francisco. Started Jul 2018; status: terminated.

02

Drugs

acetylcysteine inhalation solution
03

Conditions

asthma

Beyond the preview

Go deeper on NCT03581084.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03581084.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call